The Top 3 Trends Shaping Life Sciences M&A
David Crean, Ph.D., digs into the life sciences sector to discuss what's ahead as industry shifts shape M&A activity
M&A trends across the life sciences landscape are shifting as biopharma deals dipped in 2021 while health tech investment picks up. To dig deeper into the sector, GrowthTV welcomes David Crean, Ph.D., Managing General Partner at Equitos Venture Partners and Managing Partner at Cardiff Advisory LLC. He discusses his observations for what’s ahead as an array of factors impact the life sciences space.
Related content: Pioneering Life Science M&A with Cloud-Based Technology
